The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.

The TGF-β/Smad3 pathway plays a major role in tissue fibrosis, but the precise mechanisms are not fully understood. Here we identified microRNA miR-433 as an important component of TGF-β/Smad3-driven renal fibrosis. The miR-433 was upregulated following unilateral ureteral obstruction, a model of aggressive renal fibrosis. In vitro, overexpression of miR-433 enhanced TGF-β1-induced fibrosis, whereas knockdown of miR-433 suppressed this response. Furthermore, Smad3, but not Smad2, bound to the miR-433 promoter to induce its expression. Delivery of an miR-433 knockdown plasmid to the kidney by ultrasound microbubble-mediated gene transfer suppressed the induction and progression of fibrosis in the obstruction model. The antizyme inhibitor Azin1, an important regulator of polyamine synthesis, was identified as a target of miR-433. Overexpression of miR-433 suppressed Azin1 expression, while, in turn, Azin1 overexpression suppressed TGF-β signaling and the fibrotic response. Thus, miR-433 is an important component of TGF-β/Smad3-induced renal fibrosis through the induction of a positive feedback loop to amplify TGF-β/Smad3 signaling, and may be a potential therapeutic target in tissue fibrosis.

[1]  S. Friedman,et al.  A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis , 2011, Hepatology.

[2]  A. Roberts Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.

[3]  H. Lan,et al.  Latent TGF-beta1 protects against crescentic glomerulonephritis. , 2008, Journal of the American Society of Nephrology : JASN.

[4]  K. Lai,et al.  Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  F. Strutz,et al.  The importance of tubulointerstitial damage in progressive renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  H. Lan,et al.  The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential , 2011, Diabetes.

[7]  Yong Liu,et al.  MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor β1: a novel role of miR-382 , 2010, Nucleic acids research.

[8]  S. H. Kim,et al.  Identification of differentially expressed genes in normal and tumor human gastric tissue. , 2000, Genomics.

[9]  H. Haller,et al.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease , 2011, Nature Reviews Nephrology.

[10]  Xiao-ming Meng,et al.  Diverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitro , 2012, The Journal of pathology.

[11]  B. Bass,et al.  Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion. , 2000, American journal of physiology. Cell physiology.

[12]  Xiao-ming Meng,et al.  miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[13]  K. Lai,et al.  Essential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition , 2010, The Journal of pathology.

[14]  E. Bottinger,et al.  Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[15]  L. Truong,et al.  Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. , 2008, The American journal of pathology.

[16]  A. Szalai,et al.  C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes , 2011, Diabetologia.

[17]  T. Haverty,et al.  Mechanisms of tubulointerstitial fibrosis , 2004, Current opinion in nephrology and hypertension.

[18]  Tso‐Hsiao Chen,et al.  Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. , 2005, The American journal of pathology.

[19]  Bo Liu,et al.  Down-regulated miR-9 and miR-433 in human gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[20]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[21]  Ivan Ovcharenko,et al.  rVISTA 2.0: evolutionary analysis of transcription factor binding sites , 2004, Nucleic Acids Res..

[22]  B. Bass,et al.  Expression of the transforming growth factor-β gene during growth inhibition following polyamine depletion. , 1998, American journal of physiology. Cell physiology.

[23]  C. Lau,et al.  C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II-Induced Hypertensive Cardiac Disease , 2010, Hypertension.

[24]  Y. Sheen,et al.  IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. , 2006, Kidney international.

[25]  Ling Yu,et al.  Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. , 2004, Kidney international.

[26]  K. Lai,et al.  Mechanism of chronic aristolochic acid nephropathy: role of Smad3. , 2010, American journal of physiology. Renal physiology.

[27]  Cheuk-Man Yu,et al.  TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. , 2011, Journal of the American Society of Nephrology : JASN.

[28]  Xiaowei Wang miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.

[29]  R. Kucherlapati,et al.  Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.

[30]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[31]  C. Kahana Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. , 2009, Essays in biochemistry.

[32]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[33]  H. Lan,et al.  Chemokines in renal injury. , 2011, Journal of the American Society of Nephrology : JASN.

[34]  H. Lan,et al.  Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  J. Rossi,et al.  TGF-β activates Akt kinase via a microRNA-dependent amplifying circuit targeting PTEN , 2009, Nature Cell Biology.

[36]  A. Hatzigeorgiou,et al.  A guide through present computational approaches for the identification of mammalian microRNA targets , 2006, Nature Methods.

[37]  J. Zavadil,et al.  Transforming Growth Factor-β and microRNA:mRNA Regulatory Networks in Epithelial Plasticity , 2007, Cells Tissues Organs.

[38]  Xiao-ming Meng,et al.  miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes , 2013, Diabetologia.

[39]  S. Hubchak,et al.  TGF-β signal transduction and mesangial cell fibrogenesis , 2003 .

[40]  A. Keren-Paz,et al.  Antizyme Affects Cell Proliferation and Viability Solely through Regulating Cellular Polyamines* , 2011, The Journal of Biological Chemistry.

[41]  A. Roberts,et al.  Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.

[42]  C. Kahana,et al.  The Role of Polyamines in Supporting Growth of Mammalian Cells Is Mediated through Their Requirement for Translation Initiation and Elongation*♦ , 2010, The Journal of Biological Chemistry.

[43]  H. Lan,et al.  TGF-β/Smad signaling in kidney disease. , 2012, Seminars in nephrology.

[44]  R. Quigg,et al.  MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  R. Morishita,et al.  Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. , 2003, Journal of the American Society of Nephrology : JASN.

[46]  Xiao-ming Meng,et al.  Role of the TGF-β/BMP-7/Smad pathways in renal diseases. , 2013, Clinical science.

[47]  Robert H. Jenkins,et al.  Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[48]  Compagnone Alessandra,et al.  Polyamines modulate epithelial-to-mesenchymal transition , 2012, Amino Acids.

[49]  A. Kulkarni,et al.  Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. , 1996, Blood.

[50]  T. Pawson,et al.  Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses , 2006, The Journal of Immunology.

[51]  K. Sharma,et al.  Potential Role of TGF-β in Diabetic Nephropathy , 1998, Mineral and Electrolyte Metabolism.

[52]  John J Rossi,et al.  MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors , 2007, Proceedings of the National Academy of Sciences.

[53]  H. Lan,et al.  Transforming growth factor-β and Smads. , 2011, Contributions to nephrology.

[54]  H. Lan,et al.  Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. , 2005, Kidney international. Supplement.

[55]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[56]  H. Lan,et al.  Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. , 2007, Journal of the American Society of Nephrology : JASN.

[57]  Xiao-ming Meng,et al.  Smad3-mediated upregulation of miR-21 promotes renal fibrosis. , 2011, Journal of the American Society of Nephrology : JASN.

[58]  J. Kopp,et al.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. , 2010, Journal of the American Society of Nephrology : JASN.

[59]  H. Lan Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation , 2011, International journal of biological sciences.

[60]  Huifang M. Zhang,et al.  Activation of TGF-β-Smad signaling pathway following polyamine depletion in intestinal epithelial cells , 2003 .

[61]  K. Lai,et al.  Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. , 2008, American journal of physiology. Renal physiology.

[62]  A. Roberts,et al.  Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. , 2003, The Journal of clinical investigation.

[63]  Hong-Jian Zhu,et al.  Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. , 2002, Journal of the American Society of Nephrology : JASN.

[64]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[65]  R. Atkins,et al.  A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry. , 1996, Journal of immunological methods.

[66]  H. Lan,et al.  Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–&bgr;–Dependent and –Independent Smad Pathways: The Role of Smad3 , 2009, Hypertension.

[67]  Xiao-ming Meng,et al.  Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. , 2012, Kidney international.

[68]  K. Sharma,et al.  Mechanisms of kidney fibrosis and the role of antifibrotic therapies , 2009, Current opinion in nephrology and hypertension.

[69]  A. Szalai,et al.  C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice , 2011, Laboratory Investigation.